Partners
Francis A. deSouza
ILMN
NASDAQ
Biotechnology
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
*latest update 2020-05-13
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Baillie Gifford and Company | 17,619,078 | Mar 30, 2020 | 11.99% | 4,812,122,583 |
| Vanguard Group, Inc. (The) | 11,749,136 | Mar 30, 2020 | 7.99% | 3,208,924,024 |
| Blackrock Inc. | 10,945,014 | Mar 30, 2020 | 7.45% | 2,989,302,223 |
| State Street Corporation | 6,085,846 | Mar 30, 2020 | 4.14% | 1,662,166,259 |
| Edgewood Management Company | 4,862,068 | Mar 30, 2020 | 3.31% | 1,327,928,012 |
| Capital Research Global Investors | 4,213,566 | Mar 30, 2020 | 2.87% | 1,150,809,145 |
| Sands Capital Management, Inc. | 3,262,948 | Mar 30, 2020 | 2.22% | 891,176,357 |
| Morgan Stanley | 2,912,817 | Mar 30, 2020 | 1.98% | 795,548,579 |
| Bank Of New York Mellon Corporation | 2,617,521 | Mar 30, 2020 | 1.78% | 714,897,335 |
| Geode Capital Management, LLC | 2,433,358 | Mar 30, 2020 | 1.66% | 664,598,736 |